Mary Bird Perkins Cancer Center is now enrolling patients into phase 1 clinical trials, an expansion of its services, the center announced this morning. The center’s first phase 1 trial is to treat large B cell lymphoma, or DLBCL, a common but aggressive cancer. From 2017-2020, there were 357 patients diagnosed with the disease in
Mary Bird Perkins expands research to include phase 1 clinical trials
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
